Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Recombinant ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) decreases vascular calcification and prevents osteomalacia in a rat model of chronic kidney disease.
Journal: JBMR plus
Published: November 26, 2024
ENPP1 enzyme replacement therapy improves ectopic calcification but does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia.
Journal: JBMR plus
Published: May 10, 2024
INZ-701, a recombinant ENPP1 enzyme, prevents ectopic calcification in an Abcc6-/- mouse model of pseudoxanthoma elasticum.
Journal: Experimental dermatology
Published: March 24, 2022
INZ-701 Prevents Ectopic Tissue Calcification and Restores Bone Architecture and Growth in ENPP1-Deficient Mice.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: December 20, 2020
Showing 1-6 of 6
Last Updated: 09/26/2026